TYRA
TYRA
NASDAQ · Biotechnology

Tyra Biosciences Inc

$28.32
-0.75 (-2.58%)
As of Jun 21, 10:06 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -33.8% upside
Low Target $15.89
Average Target $18.74
High Target $31.24
Current Price $28.32
Current
$28.32
Target
$18.74
$15.89 $18.74 avg $31.24
Scenario Analysis
Bear Case
$15.89
-43.9%
Low target
Base Case
$18.74
-33.8%
Avg target
Bull Case
$31.24
+10.3%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$40.65
-30.3% from high
52-Week Low
$8.98
+215.4% from low
Target vs 52W High
$18.74
-53.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%